KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Non-Current Assets (2016 - 2025)

Eli Lilly's Non-Current Assets history spans 17 years, with the latest figure at $56.8 billion for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 23.65% year-over-year to $56.8 billion; the TTM value through Dec 2025 reached $208.9 billion, up 22.46%, while the annual FY2025 figure was $56.8 billion, 23.65% up from the prior year.
  • Non-Current Assets reached $56.8 billion in Q4 2025 per LLY's latest filing, up from $52.9 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $56.8 billion in Q4 2025 to a low of $29.8 billion in Q3 2022.
  • Average Non-Current Assets over 5 years is $38.1 billion, with a median of $34.2 billion recorded in 2023.
  • Peak YoY movement for Non-Current Assets: fell 1.85% in 2022, then rose 26.59% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $30.4 billion in 2021, then rose by 3.63% to $31.5 billion in 2022, then rose by 21.69% to $38.3 billion in 2023, then grew by 20.1% to $46.0 billion in 2024, then increased by 23.65% to $56.8 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Non-Current Assets are $56.8 billion (Q4 2025), $52.9 billion (Q3 2025), and $51.1 billion (Q2 2025).